AstraZeneca · 13 hours ago
Senior Director, Global Oncology RWD Platform
Gaithersburg, MD
Full-time
Onsite
Director/Executive
$229K/yr - $344K/yr
10+ years expAstraZeneca is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of prescription medicines. They are seeking a Senior Director for the Global Oncology RWD Platform to drive the creation and maintenance of a multi-asset platform for real world data generation in oncology, ensuring timely and impactful evidence generation across their oncology portfolio.
BiotechnologyMedical DeviceHealthcarePharmaceuticalBiopharmaHealth CareMedicalPrecision Medicine
Responsibilities
This person will be responsible for multiple initiatives within NGS and EG2P, and therefore must be comfortable with ambiguity and able to flex across different workstreams, cross-functional teams and discussion topics
Identify and assess potential new partners for potential inclusion in APOLLO and conduct feasibility assessments to ensure fit for purpose with APOLLO strategy of expanding access to real world oncology data
Develop and implement a Roadmap to prepare the organization for APOLLO RWD ingestion and utilization
Develop a communication plan for internal AZ partners, including Evidence Generation to Publications (EG2P), broader Global Medical Affairs organization, regional and local teams regarding APOLLO status
In collaboration with other EG2P or OBU teams, develop dashboards summarizing key metrics from APOLLO RWD sources for internal AZ partners
Create and implement strategies that drive the implementation of APOLLO, ensuring availability of timely and meaningful data to support AZ’s global oncology real world evidence needs
Foster collaborative relationships with external experts to help shape future APOLLO initiatives
Provide leadership and mentoring to teams and individuals to upskill and develop future capabilities in line with AstraZeneca’s dedication to a culture of performance development and lifelong learning
Ensure that all Medical and business activities are carried out in compliance with AZ standards, standard operating procedures, and external regulations
Qualification
Required
Minimum 10 years experience in the pharmaceutical industry with advanced degree in epidemiology, outcomes research, statistics and/or related subject areas
Demonstrated experience building real world data (RWD) assets and real world evidence (RWE) generation
Deep understanding of the utilization of RWD for multiple use cases, and ability to guide decisions regarding data structure, inclusion criteria, etc, to support those use cases
In-depth expertise with research methods for real world research, HEOR projects including pharmacoepidemiologic models
Proven track record of using tools for data curation / abstraction of unstructured information from electronic health records
Strong verbal and written communication skills, particularly around research methods and use of RWD in global and local settings
Preferred
PhD in relevant area (Health Economics, Public Health, etc)
Expert reputation within the business and industry related to RWE
Scientific and business expertise in oncology with a strong understanding of key global and regional issues and concerns
Recognized as a subject matter authority with deep technical expertise in global RWE generation
Extensive knowledge of the latest technical and regulatory expectations related to generation / use of RWD
Familiarity with the latest research and thinking in data visualization
Experience in building dashboards or other tools for summarizing data
Effective problem and conflict resolution skills and validated team focus
Benefits
Eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Pascal Soriot
Executive Director and Chief Executive Officer
Aradhana Sarin
Group CFO and Executive Director
Recent News
2026-02-12
2026-02-12
2026-02-12
Company data provided by crunchbase